Paris
France
43
2026-04-23
37
2025-09-16
These are the the leading inventors for applications assigned to Eligo Bioscience:
Eligo Bioscience based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
PHAGE-DERIVED PARTICLES FOR IN SITU DELIVERY OF DNA PAYLOAD INTO C. ACNES POPULATION
#2 | 2025-12-18METHOD FOR TREATING C. ACNES BACTERIA-ASSOCIATED DISEASES
#3 | 2025-05-08COSMETIC USE OF ENGINEERED POSTBIOTICS COMPRISING BACTERIOCINS AND/OR ENDOLYSINS
#4 | 2025-01-30 ✅ Patent 12,414,962 granted on 2025-09-16METHOD FOR TREATING C. ACNES BACTERIA-ASSOCIATED DISEASES
#5 | 2024-08-01 ✅ Patent 12,460,216 granted on 2025-11-04PHAGE-DERIVED PARTICLES FOR IN SITU DELIVERY OF DNA PAYLOAD INTO C. ACNES POPULATION
#6 | 2024-07-25PRODUCTION OF LYTIC PHAGES
#7 | 2024-03-28 ✅ Patent 12,098,372 granted on 2024-09-24Microbiome modulation of a host by delivery of DNA payloads with minimized spread
#8 | 2024-02-08 ✅ Patent 11,970,701 granted on 2024-04-30Phage-derived particles for in situ delivery of DNA payload into population
#9 | 2024-02-01 ✅ Patent 12,454,696 granted on 2025-10-28CUTIBACTERIUM ACNES RECOMBINANT PHAGES, METHOD OF PRODUCTION AND USES THEREOF
#10 | 2024-01-11 ✅ Patent 11,952,595 granted on 2024-04-09Production of lytic phages
#11 | 2023-10-19MODULATION OF MICROBIOTA FUNCTION BY GENE THERAPY OF THE MICROBIOME TO PREVENT, TREAT OR CURE MICROBIOME-ASSOCIATED DISEASES OR DISORDERS
#12 | 2023-09-07 ✅ Patent 11,939,598 granted on 2024-03-26Production bacterial cells and use thereof in production methods
#13 | 2023-07-20 ✅ Patent 11,970,716 granted on 2024-04-30Transcriptional control in prokaryotic cells using DNA-binding repressors
#14 | 2023-07-13 ✅ Patent 12,214,070 granted on 2025-02-04Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins
#15 | 2023-07-06 ✅ Patent 11,839,645 granted on 2023-12-12Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins
#16 | 2023-04-13 ✅ Patent 11,690,880 granted on 2023-07-04Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders
#17 | 2023-03-09 ✅ Patent 11,840,695 granted on 2023-12-12Recombinant phages comprising transgenes
#18 | 2022-11-17 ✅ Patent 11,739,304 granted on 2023-08-29Production of lytic phages
#19 | 2022-11-17 ✅ Patent 11,697,802 granted on 2023-07-11Production bacterial cells and use thereof in production methods
#20 | 2022-11-03 ✅ Patent 12,214,022 granted on 2025-02-04Sequence-specific antimicrobials by blocking DNA repair
#21 | 2022-09-22 ✅ Patent 11,541,106 granted on 2023-01-03Method for killing bacteria with an engineered postbiotic
#22 | 2022-09-22 ✅ Patent 11,633,348 granted on 2023-04-25Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins
#23 | 2022-07-28 ✅ Patent 11,534,467 granted on 2022-12-27Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders
#24 | 2022-05-05 ✅ Patent 11,473,093 granted on 2022-10-18recombinant phages, method of production and uses thereof
#25 | 2022-05-05 ✅ Patent 11,820,989 granted on 2023-11-21Phage-derived particles for in situ delivery of DNA payload into population
#26 | 2022-05-05 ✅ Patent 11,746,352 granted on 2023-09-05Microbiome modulation of a host by delivery of DNA payloads with minimized spread
#27 | 2022-04-21 ✅ Patent 11,584,781 granted on 2023-02-21Chimeric receptor binding proteins resistant to proteolytic degradation
#28 | 2022-04-14 ✅ Patent 11,512,116 granted on 2022-11-29Chimeric receptor binding proteins for use in bacterial delivery vehicles
#29 | 2022-02-03 ✅ Patent 11,376,286 granted on 2022-07-05Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders
#30 | 2021-12-09 ✅ Patent 11,946,056 granted on 2024-04-02Optimized vector for delivery in microbial populations
#31 | 2021-12-09 ✅ Patent 11,952,594 granted on 2024-04-09Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof
#32 | 2021-10-14 ✅ Patent 11,617,773 granted on 2023-04-04Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy
#33 | 2021-10-14 ✅ Patent 11,224,621 granted on 2022-01-18Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders
#34 | 2021-07-01BACTERIAL DELIVERY VEHICLES FOR IN VIVO DELIVERY OF A DNA PAYLOAD
#35 | 2021-01-07 ✅ Patent 11,421,222 granted on 2022-08-23Bacterial delivery vehicles comprising tracer nucleic acid sequences
#36 | 2020-12-24 ✅ Patent 11,078,490 granted on 2021-08-03Optimized vector for delivery in microbial populations
#37 | 2020-09-17 ✅ Patent 11,584,918 granted on 2023-02-21Transcriptional control in prokaryotic cells using DNA-binding repressors
#38 | 2020-09-03 ✅ Patent 11,236,133 granted on 2022-02-01Chimeric receptor binding proteins for use in bacterial delivery vehicles
#39 | 2020-08-06 ✅ Patent 11,905,516 granted on 2024-02-20Optimized vector for delivery in microbial populations
#40 | 2020-06-25 ✅ Patent 11,208,437 granted on 2021-12-28Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles
#41 | 2020-06-18 ✅ Patent 11,661,443 granted on 2023-05-30Chimeric receptor binding proteins for use in bacterial delivery vehicles
#42 | 2020-04-23 ✅ Patent 11,357,831 granted on 2022-06-14Sequence-specific antimicrobials by blocking DNA repair
#43 | 2020-02-06 ✅ Patent 10,808,254 granted on 2020-10-20Optimized vector for delivery in microbial populations
Also check out Eligo Bioscience's (Paris, France) applicant profile with 45 patent applications submitted.
154604 ⎘